On March 27 Jounce Therapeutics (JNCE on Nasdaq, filings) has entered a transaction to be acquired by Concentra Biosciences. The company will be acquired for 1.85 USD plus a non-tradable CVR. I expect the transaction to be close soon: in one or two months. See also the
Free CVR with Jounce Therapeutics (JNCE)
Free CVR with Jounce Therapeutics (JNCE)
Free CVR with Jounce Therapeutics (JNCE)
On March 27 Jounce Therapeutics (JNCE on Nasdaq, filings) has entered a transaction to be acquired by Concentra Biosciences. The company will be acquired for 1.85 USD plus a non-tradable CVR. I expect the transaction to be close soon: in one or two months. See also the